vs

Side-by-side financial comparison of Editas Medicine, Inc. (EDIT) and NATHANS FAMOUS, INC. (NATH). Click either name above to swap in a different company.

NATHANS FAMOUS, INC. is the larger business by last-quarter revenue ($34.3M vs $24.7M, roughly 1.4× Editas Medicine, Inc.). NATHANS FAMOUS, INC. runs the higher net margin — 9.0% vs -22.7%, a 31.7% gap on every dollar of revenue. On growth, NATHANS FAMOUS, INC. posted the faster year-over-year revenue change (8.9% vs -19.2%). NATHANS FAMOUS, INC. produced more free cash flow last quarter ($5.7M vs $-36.4M). Over the past eight quarters, Editas Medicine, Inc.'s revenue compounded faster (366.9% CAGR vs 8.8%).

Editas Medicine, Inc.,, is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.

Nathan's Famous, Inc., is an American company that operates a chain of fast-food restaurants specializing in hot dogs. The original Nathan's restaurant stands at the corner of Surf and Stillwell avenues in the Coney Island neighborhood of Brooklyn, New York City. Its restaurants are primarily in the Northeastern United States. The company's headquarters are at One Jericho Plaza in Jericho, part of Oyster Bay, New York.

EDIT vs NATH — Head-to-Head

Bigger by revenue
NATH
NATH
1.4× larger
NATH
$34.3M
$24.7M
EDIT
Growing faster (revenue YoY)
NATH
NATH
+28.0% gap
NATH
8.9%
-19.2%
EDIT
Higher net margin
NATH
NATH
31.7% more per $
NATH
9.0%
-22.7%
EDIT
More free cash flow
NATH
NATH
$42.1M more FCF
NATH
$5.7M
$-36.4M
EDIT
Faster 2-yr revenue CAGR
EDIT
EDIT
Annualised
EDIT
366.9%
8.8%
NATH

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
EDIT
EDIT
NATH
NATH
Revenue
$24.7M
$34.3M
Net Profit
$-5.6M
$3.1M
Gross Margin
32.6%
Operating Margin
-31.3%
14.9%
Net Margin
-22.7%
9.0%
Revenue YoY
-19.2%
8.9%
Net Profit YoY
87.6%
-31.2%
EPS (diluted)
$0.03
$0.75

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EDIT
EDIT
NATH
NATH
Q4 25
$24.7M
$34.3M
Q3 25
$7.5M
$45.7M
Q2 25
$3.6M
$47.0M
Q1 25
$4.7M
$30.8M
Q4 24
$30.6M
$31.5M
Q3 24
$61.0K
$41.1M
Q2 24
$513.0K
$44.8M
Q1 24
$1.1M
$29.0M
Net Profit
EDIT
EDIT
NATH
NATH
Q4 25
$-5.6M
$3.1M
Q3 25
$-25.1M
$5.2M
Q2 25
$-53.2M
$8.9M
Q1 25
$-76.1M
$4.2M
Q4 24
$-45.4M
$4.5M
Q3 24
$-62.1M
$6.0M
Q2 24
$-67.6M
$9.3M
Q1 24
$-62.0M
$3.9M
Gross Margin
EDIT
EDIT
NATH
NATH
Q4 25
32.6%
Q3 25
29.1%
Q2 25
39.5%
Q1 25
38.7%
Q4 24
37.9%
Q3 24
36.7%
Q2 24
43.6%
Q1 24
43.3%
Operating Margin
EDIT
EDIT
NATH
NATH
Q4 25
-31.3%
14.9%
Q3 25
-325.4%
16.4%
Q2 25
-1440.6%
27.2%
Q1 25
-1635.1%
20.7%
Q4 24
-152.2%
21.4%
Q3 24
-107649.2%
23.4%
Q2 24
-14016.2%
30.7%
Q1 24
-5902.3%
23.5%
Net Margin
EDIT
EDIT
NATH
NATH
Q4 25
-22.7%
9.0%
Q3 25
-333.0%
11.4%
Q2 25
-1487.8%
19.0%
Q1 25
-1633.5%
13.8%
Q4 24
-148.3%
14.2%
Q3 24
-101870.5%
14.7%
Q2 24
-13178.8%
20.7%
Q1 24
-5458.1%
13.5%
EPS (diluted)
EDIT
EDIT
NATH
NATH
Q4 25
$0.03
$0.75
Q3 25
$-0.28
$1.26
Q2 25
$-0.63
$2.16
Q1 25
$-0.92
$1.03
Q4 24
$-0.55
$1.10
Q3 24
$-0.75
$1.47
Q2 24
$-0.82
$2.27
Q1 24
$-0.76
$0.95

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EDIT
EDIT
NATH
NATH
Cash + ST InvestmentsLiquidity on hand
$146.6M
$24.5M
Total DebtLower is stronger
$48.7M
Stockholders' EquityBook value
$27.3M
$-15.3M
Total Assets
$186.5M
$50.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EDIT
EDIT
NATH
NATH
Q4 25
$146.6M
$24.5M
Q3 25
$165.6M
$32.2M
Q2 25
$178.5M
$26.9M
Q1 25
$221.0M
$27.8M
Q4 24
$269.9M
$23.7M
Q3 24
$265.1M
$31.2M
Q2 24
$279.1M
$26.0M
Q1 24
$296.2M
$21.0M
Total Debt
EDIT
EDIT
NATH
NATH
Q4 25
$48.7M
Q3 25
$49.3M
Q2 25
$49.9M
Q1 25
$50.5M
Q4 24
$57.4M
$51.1M
Q3 24
$59.6M
Q2 24
Q1 24
$59.6M
Stockholders' Equity
EDIT
EDIT
NATH
NATH
Q4 25
$27.3M
$-15.3M
Q3 25
$13.5M
$-5.9M
Q2 25
$19.2M
$-9.3M
Q1 25
$62.4M
$-16.5M
Q4 24
$134.3M
$-19.0M
Q3 24
$175.6M
$-21.3M
Q2 24
$232.0M
$-25.5M
Q1 24
$294.4M
$-32.9M
Total Assets
EDIT
EDIT
NATH
NATH
Q4 25
$186.5M
$50.9M
Q3 25
$201.8M
$62.9M
Q2 25
$210.6M
$63.4M
Q1 25
$263.7M
$53.5M
Q4 24
$341.6M
$48.7M
Q3 24
$327.6M
$57.7M
Q2 24
$384.8M
$58.5M
Q1 24
$440.3M
$48.9M
Debt / Equity
EDIT
EDIT
NATH
NATH
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.43×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EDIT
EDIT
NATH
NATH
Operating Cash FlowLast quarter
$-36.4M
$5.8M
Free Cash FlowOCF − Capex
$-36.4M
$5.7M
FCF MarginFCF / Revenue
-147.3%
16.6%
Capex IntensityCapex / Revenue
0.2%
0.2%
Cash ConversionOCF / Net Profit
1.87×
TTM Free Cash FlowTrailing 4 quarters
$22.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EDIT
EDIT
NATH
NATH
Q4 25
$-36.4M
$5.8M
Q3 25
$-30.8M
$10.2M
Q2 25
$-50.2M
$-220.0K
Q1 25
$-47.8M
$6.8M
Q4 24
$-50.8M
$3.6M
Q3 24
$-52.6M
$9.8M
Q2 24
$-57.1M
$5.0M
Q1 24
$-49.9M
$6.4M
Free Cash Flow
EDIT
EDIT
NATH
NATH
Q4 25
$-36.4M
$5.7M
Q3 25
$-31.3M
$10.0M
Q2 25
$-335.0K
Q1 25
$-47.9M
$6.7M
Q4 24
$-51.3M
$3.6M
Q3 24
$-55.5M
$9.7M
Q2 24
$-60.6M
$5.0M
Q1 24
$-51.7M
$6.3M
FCF Margin
EDIT
EDIT
NATH
NATH
Q4 25
-147.3%
16.6%
Q3 25
-414.6%
21.9%
Q2 25
-0.7%
Q1 25
-1028.6%
21.9%
Q4 24
-167.6%
11.4%
Q3 24
-90998.4%
23.7%
Q2 24
-11804.3%
11.1%
Q1 24
-4558.9%
21.9%
Capex Intensity
EDIT
EDIT
NATH
NATH
Q4 25
0.2%
0.2%
Q3 25
5.7%
0.4%
Q2 25
0.0%
0.2%
Q1 25
2.4%
0.2%
Q4 24
1.8%
0.1%
Q3 24
4788.5%
0.2%
Q2 24
681.1%
0.1%
Q1 24
164.8%
0.2%
Cash Conversion
EDIT
EDIT
NATH
NATH
Q4 25
1.87×
Q3 25
1.95×
Q2 25
-0.02×
Q1 25
1.60×
Q4 24
0.81×
Q3 24
1.63×
Q2 24
0.54×
Q1 24
1.64×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EDIT
EDIT

Segment breakdown not available.

NATH
NATH

Branded Product Program$23.7M69%
Product Licensing$7.4M22%
Company Operated Restaurants$1.6M5%
Franchise Fees And Royalties$1.0M3%

Related Comparisons